查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827760

2025年全球微针药物输送系统市场报告

Microneedle Drug Delivery Systems Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，微针给药系统的市场规模迅速扩张，从2024年的50.1亿美元成长到2025年的58.6亿美元，复合年增长率为17.1%。预测期内的成长可归因于无痛给药、增强患者依从性、慢性病管理、美容和美学应用以及疫苗接种。

预计未来几年微针给药系统市场将快速成长，到2029年将达到112.8亿美元，复合年增长率为17.8%。预测期内的成长主要归功于化妆品和美容应用、新兴疗法、儿科和老年医学应用、全球健康计划以及就地检验。预测期内的主要趋势包括智慧微针、材料科学的进步、穿戴式技术的进步、可生物降解材料以及持续血糖监测。

微针药物输送系统是一种先进的医疗设备，它利用一系列微米大小的针头，透过皮肤微创地输送药物、疫苗和其他治疗，穿透角质层而不到达更深的神经末梢，最大限度地减少疼痛和不适。

微针药物传输系统的主要技术包括固态微针技术、中空微针技术和可溶解微针技术。固体微针技术利用强化学涂层将干燥的胜肽附着在微针阵列的尖端。这些固态微针通常微米为250至微米，呈贴片状，可在室温下保存。微针药物输送系统用于药物输送、疫苗接种和其他治疗应用。它们广泛应用于各种场合，包括诊断实验室、生命科学实验室、医院、门诊手术中心和其他医疗机构。

2025年春季，美国关税飙升及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司最新报告系列的一部分，该系列提供微针给药系统市场统计数据，例如全球市场规模、区域份额、微针给药​​系统市场份额的竞争对手、微针给药​​系统的详细细分市场、市场趋势和商机，以及在微针给药系统行业取得成功所需的其他数据。本微针给药系统市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年的预测成长率为17.8%，较我们先前对该市场的预测略有下降0.2%。下降主要源自于美国与其他国家之间关税的影响。此影响将直接影响美国，包括对韩国生物相容性聚合物树脂的关税上调，以及无痛疫苗贴片和经皮给药系统成本的上升，可能影响疫苗接种计画。此外，由于互惠关税以及贸易紧张局势和限制措施升级对全球经济和贸易的负面影响，该影响也将更加广泛。

预计不断增长的研究工作和疫苗接种需求将推动微针给药系统市场的成长。研究人员正在考虑将微针作为替代方案，以最大程度地减少收件人的疼痛。微针贴片最初是为流感和麻疹疫苗开发的，现在正用于接种 COVID-19 疫苗。例如，英国政府国家统计局在 2024 年 4 月预测，英国政府在研发 (R&D) 上的净支出（不包括对欧盟研发预算的贡献）将从 2021 年的 153.7 亿美元（140 亿英镑）增加到 2022 年的 170.1 亿美元（155 亿英镑），增幅为 10.5%。包括对欧盟研发预算和知识转移活动的贡献，预计 2022 年研发净支出将达到 180.6 亿美元（164.0 亿英镑），比 2021 年的 164.6 亿美元（150.0 亿英镑）增加 8.9%。因此，有关疫苗接种过程的研究和需求不断增加，正在推动微针给药系统市场向前发展。

肥胖症盛行率的上升预计将推动未来微针给药系统市场的成长。肥胖症是一种由体内脂肪过多引起的疾病，会对个人健康产生负面影响。微针给药系统透过提供患者一种方便无痛的给药方法，用于肥胖症管理。例如，英国政府机构健康改善和差异办公室在 2024 年 5 月估计，到 2022-2023 年，64.0% 的 18 岁及以上英国成年人将超重或患有肥胖症。其中，26.2% 被归类为肥胖。男性超重（包括肥胖）的盛行率（69.2%）高于女性（58.6%）。然而，成年人的肥胖率在性别之间相似，男性为 26.4%，女性为 26.2%。因此，肥胖症的日益普及正在推动微针药物输送系统市场的成长。

为了提供客户可靠的服务，微针药物输送系统市场的主要企业正专注于射频微针系统等产品创新。射频微针系统是一种微创技术，它整合了微针和射频能源，以改善药物传输并刺激皮肤胶原蛋白的生成，用于治疗和美容目的。例如，2023 年 2 月，美国医疗和美容设备製造商 Candela 推出了 Profound Matrix 系统。这个多应用系统包括 Sublime、Sublative RF 和尖端的 Matrix Pro施用器。 Sublime 和 Sublative RF 都利用双极射频 (RF) 技术来减少细纹和皱纹的出现，而 Matrix Pro 旨在刺激胶原蛋白的再生和生成。 Matrix Pro 是施用器旨在再生胶原蛋白和促进胶原蛋白生成的涂抹器。

微针给药系统市场的主要企业正在建立伙伴关係以提高盈利。例如，2024 年 1 月，美国医疗和美容治疗系统製造商 Cynosure 与美国美容皮肤科提供者 LaserAway 合作，将 Potenza RF 微针技术扩展到全国 LaserAway 商店。此次合作将使 LaserAway 能够为美国更广泛的患者群体提供射频微针治疗。提案强调，Potenza 是一款四模式射频微针设备，将增强临床医生的客製化选项，并提升射频微针技术的能力。

2022年11月，美国药物输送公司Kindeva Drug Delivery与Meridian Medical Technologies合併。 Kindeva Drug Delivery与Meridian Medical Technologies的合併将专注于多项关键技术，包括透过自动注射器进行的肠外给药、吸入装置、经皮给药系统和皮内给药技术。 Meridian Medical Technologies是一家专注于药物传输系统的美国製造商。

微针药物传输系统市场的主要企业包括 3M Company、Zosano Pharma Corporation、Becton-Dickinson Technologies、Nanopass Technologies、Corium Inc.、Valeritas Inc.、Microdermics、TheraJect Inc.、LTS Lohmann Therapie-Systeme AG、BioSerenTach (BT)、Sorran Therapntics Therapied、Rapha​​iatal、Tax​​ial. Co.Ltd.、NanoBiosciences LLC、AdminMed nanoBioSciences LLC、Nitto Denko Corporation、MyLife Technologies、Innoture Medical Technology Limited、Phillips-Medisize Corporation、Stemedica Cell Technologies Inc.、Candela Corporation、Dermaroller GmbH、Micropoint Technologies Technologies、Vaxess Technologies、Micron Biob​​ids、Micron Biob​​id、Krap​​yk、Badilla Point, Ticron​​id Inc.、Cutanos、Kimberly-Clark Corp. 与 Clearside BioMedical Inc.

2024年，微针药物输送系统市场最大的地区是北美。在微针药物输送系统市场分析中，欧洲是第二大地区。微针药物输送系统份额报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

微针药物输送系统市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。

微针药物传输系统市场包括水凝胶微针和可溶解微针的销售。该市场的价值是「工厂门口」价值，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球微针药物输送系统：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球微针药物输送系统市场：成长率分析
  • 全球微针药物输送系统市场表现：规模与成长，2019-2024
  • 全球微针给药系统市场预测：规模与成长，2024-2029年，2034年
  • 全球微针药物输送系统：总目标市场（TAM）

第六章 市场细分

  • 全球微针药物输送系统市场（技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 中空的
  • 多孔
  • 固体的
  • 其他的
  • 全球微针药物输送系统市场应用、效能及预测（2019-2024、2024-2029、2034）
  • 药物输送
  • 疫苗递送
  • 其他的
  • 全球微针药物输送系统市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 诊断实验室
  • 生命科学
  • 实验室
  • 医院
  • 门诊手术中心
  • 其他的
  • 全球微针给药系统市场：中空细分市场、类型、性能及预测（2019-2024、2024-2029、2034）
  • 实心中空微针
  • 涂层中空微针
  • 全球微针药物输送系统市场：多孔细分市场、类型、性能及预测（2019-2024、2024-2029、2034）
  • 多孔硅微针
  • 基于水凝胶的多孔微针
  • 全球微针给药系统市场：固体细分、按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 用于疫苗接种的固体微针
  • 用于药物输送的固体微针
  • 全球微针给药系统市场：其他细分市场、按类型、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 可溶解微针
  • 可生物降解的微针
  • 微量输注系统

第七章 区域和国家分析

  • 全球微针药物输送系统市场：按地区、绩效及预测，2019-2024年、2024-2029年、2034年
  • 全球微针药物输送系统市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 微针药物输送系统市场：竞争格局
  • 微针药物输送系统市场：公司简介
    • 3M Company
    • Zosano Pharma Corporation
    • Becton-Dickinson Technologies
    • Nanopass Technologies
    • Corium Inc.

第31章：其他领先和创新企业

  • Valeritas Inc.
  • Microdermics
  • TheraJect Inc.
  • LTS Lohmann Therapie-Systeme AG
  • BioSerenTach（BT）
  • Sorrento Therapeutics
  • DebIoTech
  • Raphas Co. Ltd.
  • QuadMedicine
  • Snvia Co. Ltd.
  • NanoBiosciences LLC
  • AdminMed nanoBioSciences LLC
  • Nitto Denko Corporation
  • MyLife Technologies
  • Innoture Medical Technology Limited

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年微针药物输送系统市场：提供新机会的国家
  • 2029年微针药物输送系统市场：细分市场带来新机会
  • 2029年微针药物输送系统市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r21801u

Microneedle Drug Delivery Systems are sophisticated medical devices that utilize arrays of micron-sized needles to deliver drugs, vaccines, and other therapeutic agents through the skin with minimal invasiveness. They penetrate the stratum corneum without reaching deeper nerve endings, thereby minimizing pain and discomfort.

The main types of technologies used in microneedle drug delivery systems include solid microneedle technology, hollow microneedle technology, dissolved microneedle technology, and others. In the solid microneedle method, peptides are dried onto the tips of a microneedle array, utilizing a coating of potent chemicals. These solid microneedles typically measure between 250 micrometers to 700 micrometers in length and are presented in patch form, allowing for storage at room temperature. Microneedle drug delivery systems find application in drug delivery, vaccine administration, and other therapeutic uses. They are employed in various settings such as diagnostic laboratories, life sciences, research laboratories, hospitals, ambulatory surgical centers, and other medical facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The microneedles drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides microneedle drug delivery systems market statistics, including microneedle drug delivery systems industry global market size, regional shares, competitors with a microneedle drug delivery systems market share, detailed microneedles drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the microneedle drug delivery systems industry. This microneedle drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The microneedle drug delivery systems market size has grown rapidly in recent years. It will grow from $5.01 billion in 2024 to $5.86 billion in 2025 at a compound annual growth rate (CAGR) of 17.1%. The growth in the historic period can be attributed to pain-free drug delivery, enhanced patient compliance, chronic disease management, cosmetic and aesthetic applications, vaccine administration.

The microneedle drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $11.28 billion in 2029 at a compound annual growth rate (CAGR) of 17.8%. The growth in the forecast period can be attributed to cosmetic and aesthetic applications, emergingTherapies, pediatric and geriatric use, global health initiatives, point-of-care testing. Major trends in the forecast period include smart microneedles, advancements in material science, advancements in wearable technology, biodegradable materials, continuous glucose monitoring.

The forecast of 17.8% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through increased duties on biocompatible polymer resins from South Korea, escalating costs for painless vaccine patches and transdermal drug delivery systems, potentially affecting immunization programs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing research efforts and demand for vaccination are anticipated to drive the growth of the microneedle drug delivery systems market. Researchers see microneedles as an alternative method for vaccine administration, allowing recipients to experience little to no pain. Initially developed for flu and measles vaccines, microneedle patches are now increasingly utilized for the delivery of COVID-19 vaccines as well. For example, in April 2024, the Office for National Statistics, a UK-based government agency, reported that the UK government's net expenditure on research and development (R&D), excluding contributions to the EU R&D budget, rose to $17.01 billion (£15.5 billion) in 2022, up from $15.37 billion (£14.0 billion) in 2021, reflecting a 10.5% increase. Including contributions to the EU R&D budget and knowledge transfer activities, total net expenditure on R&D reached $18.006 billion (£16.4 billion) in 2022, marking an 8.9% increase from $16.46 billion (£15.0 billion) in 2021. Thus, the rise in research and demand for the vaccination process is propelling the microneedle drug delivery systems market moving forward.

The rising prevalence of obesity is expected to drive the growth of the microneedle drug delivery systems market in the future. Obesity is a medical condition defined by an excess of body fat that can adversely affect an individual's health. Microneedle drug delivery systems are utilized for obesity management by providing a convenient and painless method for administering medications to patients. For example, in May 2024, the Office for Health Improvement and Disparities, a UK-based government agency, estimated that 64.0% of adults aged 18 and older in England were either overweight or living with obesity between 2022 and 2023. Of these individuals, 26.2% were classified as living with obesity. The prevalence of being overweight (including obesity) was higher in men (69.2%) than in women (58.6%). However, obesity rates among adults were comparable for both genders, with 26.4% of men and 26.2% of women living with obesity. Therefore, the increasing prevalence of obesity is driving the growth of the microneedle drug delivery systems market.

Major companies in the microneedle drug delivery systems market are concentrating on product innovation, such as radiofrequency microneedle systems, to deliver dependable services to their customers. A radiofrequency microneedle system is a minimally invasive technology that integrates microneedles with radiofrequency energy to improve drug delivery and stimulate collagen production in the skin for both therapeutic and cosmetic purposes. For example, in February 2023, Candela, a US-based medical aesthetic device manufacturer, introduced the Profound Matrix system. This multi-application system includes the Sublime, Sublative RF, and the cutting-edge Matrix Pro applicators. Both the Sublime and Sublative RF utilize bipolar radiofrequency (RF) technology to enhance the appearance of fine lines and wrinkles, while the Matrix Pro applicator is designed to regenerate and stimulate collagen production. It features a series of slender microneedles that deliver short-pulse RF energy to the skin, resulting in improved patient comfort, decreased downtime, and enhanced overall outcomes.

Major companies in the microneedle drug delivery systems market are forming partnerships to boost their profitability. For example, in January 2024, Cynosure, a US-based manufacturer of medical and aesthetic treatment systems, collaborated with LaserAway, a US-based provider of aesthetic dermatology, to expand the availability of the Potenza RF Microneedling technology to all LaserAway locations across the country. This partnership allows LaserAway to offer RF Microneedling to a wider patient demographic throughout the United States. Proponents emphasize that Potenza, a four-mode RF microneedling device, enhances customization options for clinicians and advances the capabilities of RF microneedling technology.

In November 2022, Kindeva Drug Delivery, a US-based drug delivery company, merged with Meridian Medical Technologies. The integration of Kindeva Drug Delivery and Meridian Medical Technologies will emphasize several key technologies, including parenteral drug delivery via autoinjectors, inhalation devices, transdermal delivery systems, and intradermal delivery techniques. Meridian Medical Technologies is a US-based manufacturer specializing in drug delivery systems.

Major companies operating in the microneedle drug delivery systems market include 3M Company, Zosano Pharma Corporation, Becton-Dickinson Technologies, Nanopass Technologies, Corium Inc., Valeritas Inc., Microdermics, TheraJect Inc., LTS Lohmann Therapie-Systeme AG, BioSerenTach (BT), Sorrento Therapeutics, Debiotech, Raphas Co. Ltd., QuadMedicine, Snvia Co. Ltd., NanoBiosciences LLC, AdminMed nanoBioSciences LLC, Nitto Denko Corporation, MyLife Technologies, Innoture Medical Technology Limited, Phillips-Medisize Corporation, Stemedica Cell Technologies Inc., Candela Corporation, Dermaroller GmbH, Micropoint Technologies, Vaxess Technologies, Micron Biomedical Inc., Kindeva Drug Delivery, Gurnet Point Capital, Moonlight Therapeutics Inc., Cutanos, Kimberly-Clark Corp., Clearside BioMedical Inc.

North America was the largest region in the microneedle drug delivery systems market in 2024. Europe was the second-largest region in the microneedle drug delivery systems market analysis. The regions covered in the microneedle drug delivery systems share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the microneedle drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The microneedle drug delivery systems market consists of sales of hydrogel microneedles and dissolvable microneedle. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Microneedle Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on microneedle drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for microneedle drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The microneedle drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technology: Hollow; Porous; Solid; Other Technologies
  • 2) By Application: Drug Delivery; Vaccine Delivery; Other Applications
  • 3) By End-User: Diagnostics Laboratories; Life Sciences; Research Laboratories; Hospitals; Ambulatory Surgical Centers; Other End-Users
  • Subsegments:
  • 1) By Hollow: Solid Hollow Microneedles; Coated Hollow Microneedles
  • 2) By Porous: Porous Silicon Microneedles; Hydrogel-Based Porous Microneedles
  • 3) By Solid: Solid Microneedles For Vaccination; Solid Microneedles For Drug Delivery
  • 4) By Other Technologies: Dissolving Microneedles; Biodegradable Microneedles; Micro-Infusion Systems
  • Companies Mentioned: 3M Company; Zosano Pharma Corporation; Becton-Dickinson Technologies; Nanopass Technologies; Corium Inc.; Valeritas Inc.; Microdermics; TheraJect Inc.; LTS Lohmann Therapie-Systeme AG; BioSerenTach (BT); Sorrento Therapeutics; Debiotech; Raphas Co. Ltd.; QuadMedicine; Snvia Co. Ltd.; NanoBiosciences LLC; AdminMed nanoBioSciences LLC; Nitto Denko Corporation; MyLife Technologies; Innoture Medical Technology Limited; Phillips-Medisize Corporation; Stemedica Cell Technologies Inc.; Candela Corporation; Dermaroller GmbH; Micropoint Technologies; Vaxess Technologies; Micron Biomedical Inc.; Kindeva Drug Delivery; Gurnet Point Capital; Moonlight Therapeutics Inc.; Cutanos; Kimberly-Clark Corp.; Clearside BioMedical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Microneedle Drug Delivery Systems Market Characteristics

3. Microneedle Drug Delivery Systems Market Trends And Strategies

4. Microneedle Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Microneedle Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Microneedle Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Microneedle Drug Delivery Systems Market Growth Rate Analysis
  • 5.4. Global Microneedle Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Microneedle Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Microneedle Drug Delivery Systems Total Addressable Market (TAM)

6. Microneedle Drug Delivery Systems Market Segmentation

  • 6.1. Global Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hollow
  • Porous
  • Solid
  • Other Technologies
  • 6.2. Global Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Delivery
  • Vaccine Delivery
  • Other Applications
  • 6.3. Global Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostics Laboratories
  • Life Sciences
  • Research Laboratories
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End-Users
  • 6.4. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Hollow, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Solid Hollow Microneedles
  • Coated Hollow Microneedles
  • 6.5. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Porous, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Porous Silicon Microneedles
  • Hydrogel-Based Porous Microneedles
  • 6.6. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Solid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Solid Microneedles For Vaccination
  • Solid Microneedles For Drug Delivery
  • 6.7. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dissolving Microneedles
  • Biodegradable Microneedles
  • Micro-Infusion Systems

7. Microneedle Drug Delivery Systems Market Regional And Country Analysis

  • 7.1. Global Microneedle Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Microneedle Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Microneedle Drug Delivery Systems Market

  • 8.1. Asia-Pacific Microneedle Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Microneedle Drug Delivery Systems Market

  • 9.1. China Microneedle Drug Delivery Systems Market Overview
  • 9.2. China Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Microneedle Drug Delivery Systems Market

  • 10.1. India Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Microneedle Drug Delivery Systems Market

  • 11.1. Japan Microneedle Drug Delivery Systems Market Overview
  • 11.2. Japan Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Microneedle Drug Delivery Systems Market

  • 12.1. Australia Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Microneedle Drug Delivery Systems Market

  • 13.1. Indonesia Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Microneedle Drug Delivery Systems Market

  • 14.1. South Korea Microneedle Drug Delivery Systems Market Overview
  • 14.2. South Korea Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Microneedle Drug Delivery Systems Market

  • 15.1. Western Europe Microneedle Drug Delivery Systems Market Overview
  • 15.2. Western Europe Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Microneedle Drug Delivery Systems Market

  • 16.1. UK Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Microneedle Drug Delivery Systems Market

  • 17.1. Germany Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Microneedle Drug Delivery Systems Market

  • 18.1. France Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Microneedle Drug Delivery Systems Market

  • 19.1. Italy Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Microneedle Drug Delivery Systems Market

  • 20.1. Spain Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Microneedle Drug Delivery Systems Market

  • 21.1. Eastern Europe Microneedle Drug Delivery Systems Market Overview
  • 21.2. Eastern Europe Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Microneedle Drug Delivery Systems Market

  • 22.1. Russia Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Microneedle Drug Delivery Systems Market

  • 23.1. North America Microneedle Drug Delivery Systems Market Overview
  • 23.2. North America Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Microneedle Drug Delivery Systems Market

  • 24.1. USA Microneedle Drug Delivery Systems Market Overview
  • 24.2. USA Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Microneedle Drug Delivery Systems Market

  • 25.1. Canada Microneedle Drug Delivery Systems Market Overview
  • 25.2. Canada Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Microneedle Drug Delivery Systems Market

  • 26.1. South America Microneedle Drug Delivery Systems Market Overview
  • 26.2. South America Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Microneedle Drug Delivery Systems Market

  • 27.1. Brazil Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Microneedle Drug Delivery Systems Market

  • 28.1. Middle East Microneedle Drug Delivery Systems Market Overview
  • 28.2. Middle East Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Microneedle Drug Delivery Systems Market

  • 29.1. Africa Microneedle Drug Delivery Systems Market Overview
  • 29.2. Africa Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Microneedle Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 30.1. Microneedle Drug Delivery Systems Market Competitive Landscape
  • 30.2. Microneedle Drug Delivery Systems Market Company Profiles
    • 30.2.1. 3M Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Zosano Pharma Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton-Dickinson Technologies Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Nanopass Technologies Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Corium Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Microneedle Drug Delivery Systems Market Other Major And Innovative Companies

  • 31.1. Valeritas Inc.
  • 31.2. Microdermics
  • 31.3. TheraJect Inc.
  • 31.4. LTS Lohmann Therapie-Systeme AG
  • 31.5. BioSerenTach (BT)
  • 31.6. Sorrento Therapeutics
  • 31.7. Debiotech
  • 31.8. Raphas Co. Ltd.
  • 31.9. QuadMedicine
  • 31.10. Snvia Co. Ltd.
  • 31.11. NanoBiosciences LLC
  • 31.12. AdminMed nanoBioSciences LLC
  • 31.13. Nitto Denko Corporation
  • 31.14. MyLife Technologies
  • 31.15. Innoture Medical Technology Limited

32. Global Microneedle Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Microneedle Drug Delivery Systems Market

34. Recent Developments In The Microneedle Drug Delivery Systems Market

35. Microneedle Drug Delivery Systems Market High Potential Countries, Segments and Strategies

  • 35.1 Microneedle Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Microneedle Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Microneedle Drug Delivery Systems Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer